Integrating molecular engineering and artificial intelligence to overcome clinical and manufacturing challenges in CAR-T therapy
This review presents an integrated perspective on molecular-level CAR-T cell engineering and AI-based computational and manufacturing systems, rather than treating them as separate domains, and examines the role of AI in both developing and processing cell-based CAR-T development of molecular constructs.
Lipi Singh, Narendra Singh, Rakesh K. Arya et al.
· Asian Journal of Oncology · 0 citations